Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Social mixing patterns within a South African township community: implications for respiratory disease transmission and control.
Johnstone-Robertson SP, Mark D, Morrow C, Middelkoop K, Chiswell M, Aquino LD, Bekker LG, Wood R.
Am J Epidemiol. 2011 Dec 1;174(11):1246-55. doi: 10.1093/aje/kwr251. Epub 2011 Nov 9.
Related citations
TB incidence in UK decreases for first time in two decades.
Moszynski P.
BMJ. 2011 Dec 9;343:d8033. doi: 10.1136/bmj.d8033. No abstract available.
Challenges of Interferon-gamma Release Assay Conversions in Serial Testing of Health Care Workers in a Tuberculosis Control Program.
Fong KS, Tomford JW, Teixeira L, Fraser TG, Vanduin D, Yen-Lieberman B, Gordon SM, Miranda C.
Chest. 2012 Jan 19. [Epub ahead of print]
Risk of progression to active tuberculosis following reinfection with Mycobacterium tuberculosis.
Andrews JR, Noubary F, Walensky RP, Cerda R, Losina E, Horsburgh CR.
Clin Infect Dis. 2012 Mar;54(6):784-91. Epub 2012 Jan 19.
High prevalence of multidrug-resistant tuberculosis, Swaziland, 2009-2010.
Sanchez-Padilla E, Dlamini T, Ascorra A, Rüsch-Gerdes S, Tefera ZD, Calain P, de la Tour R, Jochims F, Richter E, Bonnet M.
Emerg Infect Dis. 2012 Jan;18(1):29-37. doi: 10.3201/eid1801.110850.
Social determinants of tuberculosis in Europe: A prospective ecological study.
Ploubidis GB, Palmer MJ, Blackmore C, Lim TA, Manissero D, Sandgren A, Semenza JC.
Eur Respir J. 2012 Jan 20. [Epub ahead of print]
Massive monoclonal expansion of CD4 T-cells specific for a M. tuberculosis ESAT-6 peptide.
Hodapp T, Sester U, Mack U, Singh M, Meier T, Wiech E, Fisch P, Ehl S, Sester M.
Cost of illness of tuberculosis in Germany.
Diel R, Rutz S, Castell S, Schaberg T.
Influence of pre-analytic conditions on the rate of indeterminate T-SPOT.TB tests.
Zellweger A, Zellweger JP.
Eur Respir J. 2011 Jul;38(1):221-2. No abstract available.
Pre-screening with GeneXpert® MTB/RIF may increase use of isoniazid preventive therapy in antiretroviral programmes.
Lawn SD.
Int J Tuberc Lung Dis. 2011 Sep;15(9):1272-3; author reply 1273-4. No abstract available.
Reactivation or re-infection?
Esmail H.
Int J Tuberc Lung Dis. 2011 Sep;15(9):1271; author reply 1271-2. No abstract available.
Abnormal thyroid function tests in children on ethionamide treatment.
Thee S, Zöllner EW, Willemse M, Hesseling AC, Magdorf K, Schaaf HS.
Int J Tuberc Lung Dis. 2011 Sep;15(9):1191-3, i.
2010: the year in review, part I.
Lalloo UG, Nyamande K, Dheda K.
Int J Tuberc Lung Dis. 2011 Sep;15(9):1149-53. No abstract available.
Management of MDR-TB household contacts: how difficult is it to climb the mountain?
Pontali E, Sotgiu G, Migliori GB.
Int J Tuberc Lung Dis. 2011 Sep;15(9):1137-8. No abstract available.
A systematic review of gyrase mutations associated with fluoroquinolone-resistant Mycobacterium tuberculosis and a proposed gyrase numbering system.
Maruri F, Sterling TR, Kaiga AW, Blackman A, van der Heijden YF, Mayer C, Cambau E, Aubry A.
J Antimicrob Chemother. 2012 Apr;67(4):819-31. Epub 2012 Jan 25.
φ(2)GFP10, a high-intensity fluorophage, enables detection and rapid drug susceptibility testing of Mycobacterium tuberculosis directly from sputum samples.
Jain P, Hartman TE, Eisenberg N, O'Donnell MR, Kriakov J, Govender K, Makume M, Thaler DS, Hatfull GF, Sturm AW, Larsen MH, Moodley P, Jacobs WR Jr.
J Clin Microbiol. 2012 Apr;50(4):1362-9. Epub 2012 Jan 25.
India reports cases of totally drug-resistant tuberculosis.
Loewenberg S.
Lancet. 2012 Jan 21;379(9812):205. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on